Nikhil Kumar Lagisetty
About Nikhil Kumar Lagisetty
Nikhil Kumar Lagisetty is a Research Associate currently employed at Nektar Therapeutics in Hyderabad, Telangana, India. He has a background in pharmaceutical analysis and has previously worked at The Himalaya Drug Company, Mylan, and Natco Pharma Ltd.
Current Role at Nektar Therapeutics
Nikhil Kumar Lagisetty serves as a Research Associate at Nektar Therapeutics. He has been in this role since 2021 and is based in Hyderabad, Telangana, India. His responsibilities likely include conducting research and development activities, contributing to projects aimed at advancing therapeutic solutions, and collaborating with cross-functional teams within the organization.
Previous Experience at The Himalaya Drug Company
Prior to his current position, Nikhil worked at The Himalaya Drug Company in Bengaluru, Karnataka, India. He held two roles: first as a Trainee from 2019 to 2020 for one year, and then as an Associate for three months in 2020. These roles provided him with experience in the pharmaceutical industry, focusing on product development and quality assurance.
Internship Experience at Mylan
Nikhil gained valuable experience as an Intern at Mylan in Hyderabad, Telangana, India, from 2018 to 2019. His internship lasted for six months and allowed him to develop practical skills in pharmaceutical operations, enhancing his understanding of the industry and its processes.
Early Career at Natco Pharma Ltd
Nikhil began his career as a Student Trainee at Natco Pharma Ltd in Hyderabad, Telangana, India, in 2015. This position lasted for one month and marked the start of his professional journey in the pharmaceutical sector, providing foundational exposure to the industry.
Education and Academic Background
Nikhil Kumar Lagisetty holds a Master's degree in Pharmaceutical Analysis from JSS University (Jagadguru Sri Shivarathreeshwara University), Mysore, where he studied from 2017 to 2019. He also earned a Bachelor of Pharmacy (BPharm) from Nalla Narasimha Reddy Education Society Group of Institutions, completing his studies from 2013 to 2017. His educational background has equipped him with essential knowledge and skills in pharmaceutical sciences.